BOSTON, Aug. 31, 2017 /PRNewswire/ -- Benefits and treatment outcomes of the LANAP protocol - the world's first and only laser gum disease treatment FDA cleared for True Periodontal Regeneration™ - are again hot topics of discussion at the 2017 AAP Meeting. Multiple presentations discuss the advantages of this treatment modality, from the indisputable gold standard in any "healing event" – true tissue regeneration – to the emerging application of the LAPIP™ protocol for the tsunami of failing dental implants.
This independent selection of speakers by the AAP educational committee reflects the profound impact the LANAP and LAPIP protocols have in shaping the future of periodontology. The LANAP protocol remains the only laser gum disease protocol both evidence-based and scientifically validated. These same principles of laser physics and wound healing are applied to the LAPIP protocol for peri-implantitis treatment.
LANAP Regenerative Specialists educate in sessions throughout the conference:
Renowned educator Barry D. Wagenberg, DMD moderates "Saving Hopeless Teeth," on Sunday, September 10th. AAP Master Clinician, Paul Rosen, DMD, MS, PC, participates in this panel discussion on the regenerative potential of teeth previously considered beyond hope.
ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP protocol for the treatment of gum disease and the manufacturer of the PerioLase MVP-7 digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT's FDA-cleared LANAP protocol removes the fear from gum disease treatment, offering a less painful and less invasive regenerative treatment alternative to conventional surgery. The Nd:YAG PerioLase MVP-7 has the power and versatility to perform a wide range of laser procedures, including the LAPIP™ protocol for the treatment of ailing dental implants. The company's founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—"It's all about the patient."